Global Pharmacovigilance Market Report 2022: Increased Prevalence of ADRs Driving Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Pharmacovigilance Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. The global pharmacovigilance market is expected to grow at a compound annual growth rate of 10.49% over the forecast period to reach a market size of US$9.535 billion in 2027 from US$4.743 billion in 2020. Pharmacovigilance, also … [Read more…]

MedX Health Confirms Further Interim Closing and Application for Further Extension of Price Protection for Private Placement Convertible Loan Note Financing

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer–MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that, in connection with the Private Placement (the “Financing”), and further to the $250,000 first tranche closing of which was announced in its Press Release dated July 14, 2022, and its Press Release dated August 11, 2022 announcing application … [Read more…]

Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #Fortune500—Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET. Investors and other interested parties … [Read more…]

InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright 24th Annual Global Investment Conference, which runs from September 12 – … [Read more…]

May Health Solidifies Veteran Executive Team with Appointment of Women’s Health Care Leader Anne Morrissey as CEO

– Renowned reproductive health expert Dr. Robert Auerbach, OBGYN, appointed chairman of the board – May Health, formerly AblaCare, changes its name to reflect focus on restoring the lives of those with PCOS PARIS–(BUSINESS WIRE)–May Health, a clinical-stage medical device company dedicated to helping those living with the endocrine disorder polycystic ovary syndrome (PCOS), today … [Read more…]

Volastra Therapeutics to Present Preclinical Data from KIF18A Inhibitor Program Targeting Chromosomally Unstable Tumors at FASEB Aneuploidy Conference

Treatment with KIF18A inhibitor led to substantial, dose-dependent inhibition of tumor growth in multiple tumor models, with no effect on normal cells KIF18A inhibitor on track to enter the clinic in 2H 2023 NEW YORK–(BUSINESS WIRE)–Volastra Therapeutics, an oncology company focused on exploiting chromosomal instability (CIN), today announced new data from its lead program, a … [Read more…]

Envision Healthcare Demands UnitedHealthcare Pay for Patient Care

National medical group files lawsuit, urging health insurer to pay its bills and fairly reimburse clinicians providing life-saving emergency care to patients across the country NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision Healthcare, a leading national medical group, filed suit against UnitedHealthcare Services, Inc. and UnitedHealthcare Insurance Company (“United”) in U.S. federal court in Tennessee. The suit claims that … [Read more…]

United States Colorectal Cancer Market Analysis and Competitive Landscape Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Colorectal Cancer Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Colorectal Cancer pipeline products, Colorectal Cancer epidemiology, Colorectal Cancer market valuations and forecast, Colorectal Cancer drugs sales and competitive landscape in the US. The research is classified into seven sections – … [Read more…]

United States Melanoma Market Research Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape 2019-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Melanoma Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Melanoma pipeline products, Melanoma epidemiology, Melanoma market valuations and forecast, Melanoma drugs sales and competitive landscape in the US. The research is classified into seven sections – Melanoma treatment options, pipeline products, … [Read more…]

Global Doxorubicin Market Analysis Report 2022: A $1.98 Billion Market by 2028 – Increasing Approval of Generic Products – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Drug Formulation, Application, and Distribution Channel” report has been added to ResearchAndMarkets.com’s offering. The global doxorubicin market is projected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022; it is expected to register a CAGR of 6.1% … [Read more…]